US · Financial Services · Insurance - Life
EPS came in at 0.79 against a street estimate of 0.78 — a beat of 1.3%.
Analysts rate Manulife Financial Corp a buy (8 buy, 4 hold, 1 sell out of 13) with an average price target of $35.16.
CONFIDENT Strong Q2 with 16% core EPS growth, 21% APE sales growth led by Asia. LTC reinsurance deal reduces morbidity risk 24%. Canada group insurance pressured but management expects neutral outcome by year-end. Q2 2026 Hong Kong delivered strong +37% APE growth on broad-based strength. MCV (Mainland China business) ~25% of Hong Kong sales faces potential regulatory/tax headwinds but management expects structural trends to support business; too early for quantified impact. Analysts pressed China MCV tax risk, LTC deal structure trade-offs, and buyback sustainability for 18% ROE. Management reassured regulatory impact is manageable, asset retention strategy preserves earnings over capital release, and 2.5% buyback pace is adequate. 2026-08-06…
Full summary in the app.
| Fund | Stake |
|---|---|
| Royal Bank of Canada | 6.62% |
| BMO Capital Markets Corp. | 3.42% |
| Bank of Montreal | 3.38% |
| Vanguard Capital Management, LLC | 2.87% |
| TD Asset Management Inc | 1.87% |
| Mackenzie Investments | 1.78% |
| 1832 Asset Management L.P | 1.68% |
| NATIONAL BANK OF CANADA /FI/ | 1.58% |
| Action | Detail | Date |
|---|---|---|
| Dividend | $0.35 / share ex-date Aug 21, 2026 · pay Sep 21, 2026 | 2026-08-21 |
| Dividend | $0.35 / share ex-date May 29, 2026 · pay Jun 19, 2026 | 2026-05-29 |
| Dividend | $0.35 / share ex-date Feb 25, 2026 · pay Mar 19, 2026 | 2026-02-25 |
| Dividend | $0.31 / share ex-date Nov 26, 2025 · pay Dec 19, 2025 | 2025-11-26 |
| Dividend | $0.32 / share ex-date Aug 20, 2025 · pay Sep 19, 2025 | 2025-08-20 |
Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Manulife Financial Corp — free to start.
Google PlayApp StoreData updated 2026-09-18.